Here are nine key notes on orthopedic and spine device companies from the past week.
The Latest
Kevin Black, MD, is an orthopedic surgeon at Penn State Health/Milton S. Hershey (Pa.) Medical Center.
WalletHub analysts identified the best and worst places for healthcare based on three considerations: children's health and healthcare access; children's nutrition, physical activity and obesity; and children's oral health.
PeerWell unveiled a new augmented reality tool on its platform for patients recovering from spine surgery or total joint replacement.
Joint Purification Systems, an early-stage medical device company, reported a $7.8 million Series A financing round.
Johnson & Johnson reported 1.1 percent worldwide growth in the orthopedics segment for the first quarter of 2018, but believes the line will grow as the year goes on, according to the earnings call as posted in Seeking Alpha.
India revealed plans to implement a price cap on medical devices last year and the U.S. plans to review import benefits as a result, according to The Wire.
In the first quarter of 2017, Johnson & Johnson reported their orthopedics business, DePuy Synthes, had a slight 1.1 percent growth over the same period last year.
The global CT scanner market is expected to surpass $7 billon by 2024, according to a market research report by Global Market Insights.
SpinalCyte is a Houston-based tissue engineering company developing a spinal nucleus replacement solution using human dermal fibroblasts.